Home Stock

Stock Research: Hisamitsu Pharmaceutical

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Hisamitsu Pharmaceutical

TYO:4530 JP3784600003
58
  • Value
    60
  • Growth
    27
  • Safety
    Safety
    92
  • Combined
    69
  • Sentiment
    39
  • 360° View
    360° View
    58
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Hisamitsu Pharmaceutical Co Inc is a Japan-based company primarily engaged in the pharmaceutical business, including manufacturing, sales, and supply of pharmaceuticals and related products, and over-the-counter drug (OTC) operations. It also engages in urban cable television broadcasting, Internet connection services, non-life insurance agency, advertising agency, and packing material businesses. The company operates in Japan, the United States, Brazil, Vietnam, Indonesia, Europe, China, and Hong Kong. In the last fiscal year, the company had 2799 employees, a market cap of $2002 million, profits of $606 million, and revenue of $1036 million.

more

ANALYSIS: With an Obermatt 360° View of 58 (better than 58% compared with alternatives), overall professional sentiment and financial characteristics for the stock Hisamitsu Pharmaceutical are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Hisamitsu Pharmaceutical. The consolidated Value Rank has an attractive rank of 60, which means that the share price of Hisamitsu Pharmaceutical is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 60% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 92. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 39. Professional investors are more confident in 61% other stocks. The consolidated Growth Rank also has a low rank of 27, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 73 of its competitors have better growth. ...read more

more
Strongest Rank Analyst Opinions
Weakest Rank Liquidity
Country Japan
Industry Pharmaceuticals
Size Large
Website hisamitsu.co.jp
Index
Hisamitsu Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
60 42 56 59
Growth
27 67 65 33
Safety
Safety
92 86 98 100
Sentiment
39 76 34 90
360° View
360° View
58 92 77 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
15 12 20 24
Opinions Change
50 97 50 99
Pro Holdings
n/a 84 54 86
Market Pulse
68 61 65 65
Sentiment
39 76 34 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
60 42 56 59
Growth
27 67 65 33
Safety Safety
92 86 98 100
Combined
69 81 96 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
32 37 45 56
Price vs. Earnings (P/E)
42 49 47 58
Price vs. Book (P/B)
70 64 67 72
Dividend Yield
77 56 55 60
Value
60 42 56 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
17 34 41 64
Profit Growth
39 63 63 57
Capital Growth
32 59 49 42
Stock Returns
81 76 65 11
Growth
27 67 65 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
91 89 91 88
Refinancing
24 71 81 85
Liquidity
98 82 92 94
Safety Safety
92 86 98 100

Similar Stocks

Discover high‑ranked alternatives to Hisamitsu Pharmaceutical and broaden your portfolio horizons.

Daiwa House

TYO:1925
Country: Japan
Industry: Electric Utilities
Size: XX-Large
Full Stock Analysis

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

NGK Insulators

TYO:5333
Country: Japan
Industry: Industrial Machinery
Size: X-Large
Full Stock Analysis

Inpex

TYO:1605
Country: Japan
Industry: Oil & Gas Production
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews